GE HealthCare Technologies Inc. (GEHC) Earnings Call Transcripts

43 earnings calls from January 2023 to September 9, 2026

NasdaqGS US Health Care Health Care Equipment and Supplies

GE HealthCare Technologies Inc.'s Latest Earnings Call - September 9, 2026

In the Q2 2026 earnings call for GE HealthCare Technologies Inc. (GEHC:US), management reported an impressive 11% order growth and a book-to-bill ratio of 1.15, driven primarily by service contracts and a growing backlog. Revenue guidance for the second half of the year was raised, with management expressing confidence in a stronger Q3 and Q4 due to hospital budget cycles and a commitment rate of 80% for upcoming revenue. The company also anticipates a 250 basis point increase in margins year-over-year in the second half, bolstered by new product introductions and productivity initiatives.

Reported metrics

MetricValueContext
Order Growth 11% (beat) vs 8% est, +11% YoY
Book-to-Bill Ratio 1.15 (positive) indicating strong demand
Revenue Committed for Q3 80% (positive) high visibility into upcoming revenue
Margin Increase 250 basis points (positive) expected in H2 2026
PDx Growth 15% (beat) strong performance in Q2
China Market Growth low single digits (negative) expected slight decline in 2026

Guidance from management

Management raised revenue guidance for the second half of 2026, anticipating a stronger Q3 and Q4 based on hospital budget cycles and backlog management.

What management said

Yes. Yes. So I think -- look, obviously, we did see strong growth, I mean, on our core contrast media product, right, where as we see it out in the market, right, the supply is just about keeping up with demand so that from our perspective, that continues to be strong for us. Our radiopharmaceuticals continues to do well and is ramping as we would like. And then I think as we look out into the rest of the year, again...
— George Newcomb, September 9, 2026 earnings call
Not at this point in time. I mean, obviously, we're doing better than that. We'll update when we update. But obviously, it's good to see that it's outperforming what we said it would do.
— Peter Arduini, September 9, 2026 earnings call

What analysts pressed on

Analysts expressed concerns about the health of hospital budgets due to policy changes, particularly regarding the 340B program. There were also questions about the stability of the Chinese market and the impact of supply chain issues on future growth.

Main topics on the call

Read the full GE HealthCare Technologies Inc. transcript (September 9, 2026) → Summary generated from the call transcript; every figure above is stated by management on the record.

About GE HealthCare Technologies Inc.

GE HealthCare Technologies Inc. (GEHC) is a publicly listed company in the Health Care Equipment and Supplies industry, within the Health Care sector. It trades on NasdaqGS and is based in US. EarningsCalls.dev maintains a free, full-text archive of its earnings call transcripts — 43 calls on record spanning January 10, 2023 to September 9, 2026. Every transcript is split into speaker-by-speaker segments with headline metrics, free to read or available through our REST API.

Earnings Call History

EarningsCalls.dev has 43 GE HealthCare Technologies Inc. earnings call transcripts on record, spanning January 10, 2023 to September 9, 2026. Based on this history, GE HealthCare Technologies Inc. reports quarterly. The most recent call on file is dated September 9, 2026. The full list is below — each row opens the complete, free-to-read transcript.

Ticker
GEHC
Exchange
NasdaqGS
Country
US
Sector
Health Care
Industry
Health Care Equipment and Supplies
Calls on record
43
First call
January 10, 2023
Most recent
September 9, 2026
Reporting cadence
quarterly
Quarter Date
Company Conference Presentations Sep 9, 2026 Read transcript
Q2 FY2026 Jul 29, 2026 Read transcript
Company Conference Presentations Jun 3, 2026 Read transcript
Company Conference Presentations May 12, 2026 Read transcript
Q1 FY2026 Apr 29, 2026 Read transcript
Company Conference Presentations Mar 10, 2026 Read transcript
Company Conference Presentations Feb 26, 2026 Read transcript
Q4 FY2025 Feb 4, 2026 Read transcript
Company Conference Presentations Jan 13, 2026 Read transcript
Company Conference Presentations Nov 18, 2025 Read transcript
Q3 FY2025 Oct 29, 2025 Read transcript
Company Conference Presentations Sep 9, 2025 Read transcript
Company Conference Presentations Sep 4, 2025 Read transcript
Q2 FY2025 Jul 30, 2025 Read transcript
Company Conference Presentations Jun 10, 2025 Read transcript
Company Conference Presentations May 13, 2025 Read transcript
Q1 FY2025 Apr 30, 2025 Read transcript
Company Conference Presentations Feb 27, 2025 Read transcript
Q4 FY2024 Feb 13, 2025 Read transcript
Company Conference Presentations Jan 14, 2025 Read transcript
Company Conference Presentations Dec 10, 2024 Read transcript
Analyst/Investor Day Nov 21, 2024 Read transcript
Q3 FY2024 Oct 30, 2024 Read transcript
Company Conference Presentations Sep 5, 2024 Read transcript
Company Conference Presentations Sep 4, 2024 Read transcript
Q2 FY2024 Jul 31, 2024 Read transcript
Company Conference Presentations Jun 5, 2024 Read transcript
Company Conference Presentations May 14, 2024 Read transcript
Q1 FY2024 Apr 30, 2024 Read transcript
Company Conference Presentations Mar 12, 2024 Read transcript
Company Conference Presentations Feb 29, 2024 Read transcript
Q4 FY2023 Feb 6, 2024 Read transcript
Company Conference Presentations Jan 9, 2024 Read transcript
Company Conference Presentations Nov 29, 2023 Read transcript
Q3 FY2023 Oct 31, 2023 Read transcript
Company Conference Presentations Sep 12, 2023 Read transcript
Company Conference Presentations Sep 7, 2023 Read transcript
Q2 FY2023 Jul 25, 2023 Read transcript
Q1 FY2023 Apr 25, 2023 Read transcript
Company Conference Presentations Mar 14, 2023 Read transcript
Company Conference Presentations Mar 1, 2023 Read transcript
Q4 FY2022 Jan 30, 2023 Read transcript
Company Conference Presentations Jan 10, 2023 Read transcript